Article
Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
JAMA network open - 1 Dec 2021
Sheinson Daniel M, Wong William B, Meyer Craig S, Stergiopoulos Stella, Lofgren Katherine T, Flores Carlos, Adams Devon V, Fleury Mark E
Abstract excerpt
Importance: In March 2018, Medicare issued a national coverage determination (NCD) for next-generation sequencing (NGS) to facilitate access to NGS testing among Medicare beneficiaries. It is unknown whether the NCD affected health equity issues for Medicare beneficiaries and the overall population. Objective: To examine the association between the Medicare NCD and NGS use by insurance types and race and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.